Intelligent Bio Solutions Inc. Share Price
Equities
INBS
US36151G6008
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.69 USD | -3.93% | -3.24% | -33.66% |
Sales 2024 * | 4.18M 349M | Sales 2025 * | 9.43M 787M | Capitalization | 7.65M 638M |
---|---|---|---|---|---|
Net income 2024 * | -8M -668M | Net income 2025 * | -6M -501M | EV / Sales 2024 * | 1.83 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.81 x |
P/E ratio 2024 * |
-0.73
x | P/E ratio 2025 * |
-0.78
x | Employees | 51 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.4% |
1 day | -3.93% | ||
1 week | -3.24% | ||
1 month | -36.26% | ||
3 months | +7.60% | ||
6 months | +3.64% | ||
Current year | -33.66% |
Managers | Title | Age | Since |
---|---|---|---|
Harry Simeonidis
CEO | Chief Executive Officer | 56 | 01/17/01 |
Steven Boyages
CHM | Chairman | 67 | 01/20/01 |
Spiro Sakiris
DFI | Director of Finance/CFO | 63 | 01/19/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lawrence Fisher
BRD | Director/Board Member | 86 | 01/20/01 |
Harry Simeonidis
CEO | Chief Executive Officer | 56 | 01/17/01 |
Jonathan Hurd
BRD | Director/Board Member | 54 | 01/18/01 |
Date | Price | Change | Volume |
---|---|---|---|
30/24/30 | 2.69 | -3.93% | 30,168 |
29/24/29 | 2.8 | +4.09% | 40,400 |
26/24/26 | 2.69 | +8.91% | 40,699 |
25/24/25 | 2.47 | -3.89% | 52,608 |
24/24/24 | 2.57 | -7.55% | 51,711 |
End-of-day quote Nasdaq, April 30, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.66% | 7.96M | |
-19.78% | 10.81B | |
+44.90% | 3.36B | |
-33.46% | 2.22B | |
-14.31% | 2.16B | |
-28.86% | 1.55B | |
+25.34% | 1.04B | |
-3.28% | 746M | |
-35.33% | 425M | |
-46.53% | 405M |
- Stock Market
- Equities
- INBS Stock